ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model-Reference-Cited by-同舟云学术

ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model

Published:2023-06-07 Issue:11 Volume:50 Page:3192-3201
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Hautiere Marie,Vivier Delphine,Pineau Donovan,Denis Caroline,Kereselidze Dimitri,Herbet Amaury,Costa Narciso,Goncalves Victor,Selingue Erwan,Larrat Benoit,Hugnot Jean Philippe,Denat Franck,Boquet Didier,Truillet Charles^ORCID

Funder

ANR

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-023-06268-3.pdf

Reference28 articles.

1. Yang K, Wu Z, Zhang H, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21:39.

2. Rodríguez-Camacho A, Flores-Vázquez JG, Moscardini-Martelli J, et al. Glioblastoma treatment: state-of-the-art and future perspectives. Int J Mol Sci. 2022;23:7207.

3. Noch EK, Ramakrishna R, Magge R. Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance. World Neurosurg. 2018;116:505–17.